TUM – Technical University of Munich Menu
  • Research news

Researchers discover new way of defense against HBV

Attack on hepatitis B virus DNA

Scientists from the Technische Universität München and the Helmholtz Zentrum München have discovered how the viral DNA of the hepatitis B virus (HBV) can be degraded in the cell nucleus of liver cells, consequently allowing the virus to be eliminated. Viruses such as HBV can persist by depositing their genetic information (DNA) in the cell nucleus, where the DNA is normally not degraded. This prevents antiviral drugs from eliminating these viruses. But the newly discovered mechanism could make this possible without damaging the infected cell in the liver. In the current issue of the prestigious journal "Science", the scientists report that now new therapeutic possibilities are consequently opening up.

Although preventive vaccination is possible, the World Health Organization (WHO) reports that more than 240 million people around the world are currently suffering from a chronic hepatitis B infection. They face a high risk of developing liver cirrhosis or even liver cancer. In Germany alone, more than half a million people are affected. Although available antiviral medicines can control the hepatitis B virus, they cannot completely eliminate it. As a result, the HBV in the patient's liver is reactivated as soon as the treatment is discontinued.

This is due to virus DNA (cccDNA: covalently closed circular DNA) "hidden" in the cell nucleus. This virus DNA stores multiple copies of the virus in the nucleus of infected liver cells (hepatocytes) and in this way protects itself from destructive influences. The cccDNA serves as a template for the virus' own proteins and new viral genomes. An international team of scientists headed by Prof. Ulrike Protzer and Prof. Mathias Heikenwälder, Institute of Virology at the Technische Universität München and the Helmholtz Zentrum München, has now found a way to selectively attack and eliminate the viral genetic information in the cell nucleus of the liver cells without damaging the host cell in the process.

"The degradation of viral DNA in the cell nucleus that we describe represents an important mechanism in the defence against the virus", Protzer reports. "Moreover, for the first time, the results offer the possibility to develop a treatment that can heal hepatitis B."

The researchers activate the lymphotoxin-β receptor

The scientists have discovered that in addition to interferons (the immune system's defence agents), activation of the lymphotoxin β receptor in the host cell promotes certain proteins and supports their function in such a way that they chemically modulate and degrade viral cccDNA. This keeps the virus from reactivating, and also prevents the disease from breaking out again, even after the treatment has ended. On the other hand, the proteins do not influence the genetic information of the host cell itself, which here is the liver cell. "With the activation of the lymphotoxin β receptor, also combined with substances that are already available, we have a very promising new therapy concept available", Heikenwälder explains.

In addition to the Technische Universität München (TUM) and the Helmholtz Zentrum München, TUM's Klinikum rechts der Isar and the Düsseldorf, Hamburg, Mainz and Munich university hospitals also participated in the publication. International partners from Belgium, France, Switzerland and the USA also contributed.

The research was supported by the German Center for Infection Research (DZIF).

Original publication:

Lucifora, J. et al. (2014), Specific and Non-Hepatotoxic Degradation of Nuclear Hepatitis B Virus cccDNA. Science, doi: 10.1126/science.1243462

Contact:

Prof. Ulrike Protzer
Technische Universität München
Helmholtz Zentrum München - German Research Center for Environmental Health
Institute of Virology
Trogerstr. 30, 81735 München
Tel.: +49 89-4140-6886 - E-mail - Internet

Corporate Communications Center

Technical University of Munich

Article at tum.de

Percy Knolle, Professor für Molekulare Immunologie an der TUM, untersucht die Ursachen des Leberversagens. (Bild: A. Heddergott / TUM)

Liver failure caused by attack on blood vessel cells

In severe cases, a viral hepatitis infection can result in liver failure. A team from the Technical University of Munich (TUM) has now discovered how this occurs: by immune cells attacking cells in the vascular system,...

Eine therapeutische Imfpung gegen Hepatitis B könnte weltweit Millionen Menschen helfen. (Bild: tommyS / pixelio.de)

Treatment for chronic viral infections

Around 260 million people worldwide suffer from chronic Hepatitis B, which is currently incurable. A team from the Technical University of Munich (TUM) and the Helmholtz Zentrum München has developed a therapeutic vaccine...

Akram Abdellatif, Prof. Ulrike Protzer und Hanaa Gaber (von links nach rechts) haben gemeinsam die ISS Research Competition gewonnen. (Bild: M. Stobrawe / MRI)

Hepatitis C virus proteins in space

Two Egyptian researchers at Technische Universität München (TUM) have won the “International Space Station (ISS) Research Competition” in the US with their project Egypt Against Hepatitis C Virus (EGAHEP). As their prize,...

Prof. Ulrike Protzer und Dr. Felix Bohne überprüfen die Blutproben-Ergebnisse von HCV-infizierten Leberempfängern. (Bild: E. Mitterwallner / TUM)

Virus infection supports organ acceptance

Chronic hepatitis C virus infections are among the most common reasons for liver transplants. Because existing viruses also infect the new liver, the immune system is highly active there. Despite this, the new organ is not...

Die Abbildung zeigt eine Fluoreszenzaufnahme von Virus-DNA-Rad50-Card9-Komplexen (gelb) im Zytoplasma (Transmissionsbild) einer Zelle. Nach Infektion der Zelle mit einem DNA-Virus markieren die Wissenschaftler die einzelnen Moleküle, die sie in der Zelle beobachten möchten, mit unterschiedlichen fluoreszierenden Farbstoffen. In blau/magenta leuchtet die DNA, in grün Rad50 und in rot Card9.  (Bild: A. Rottach / LMU)

Starting signal for antiviral defense

Cells have to protect themselves: against damage in their genetic material for one thing, but also against attack from the outside, by viruses for example. They do this by using different mechanisms: special proteins search...

Aufnahmen von Harnsäurekristallen: Harnsäure bildet nadelförmige Kristalle, die das Immunsystem aktivieren. (Bild: K. Neumann/TUM)

A braking system for immune responses

For the first time, researchers have identified a receptor on human cells that specifically recognizes crystals. It is found on immune cells and binds uric acid crystals, which trigger gout but also control immune...